Cartesian Therapeutics
RNAC
$26.43
Share price
0.34%
Change (1 day)
2,281.08%
Change (1 year)
Categories
Earnings for Cartesian Therapeutics (RNAC)
Earnings in 2023 (TTM): -$0.24 B
According to Cartesian Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.24 B. In 2022 the company made an earning of $37.8 M an increase over its 2021 earnings that were of -$6.88 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Cartesian Therapeutics from 2015 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.24 B | -724% |
| 2022 | $37.8 M | -649.67% |
| 2021 | -$6.88 M | -89.78% |
| 2020 | -$67.32 M | 25.06% |
| 2019 | -$53.84 M | -15.68% |
| 2018 | -$63.85 M | -0.43% |
| 2017 | -$64.12 M | 83.41% |
| 2016 | -$34.96 M | 44.3% |
| 2015 | -$24.23 M |